Cortland Associates’s Kyndryl KD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.9M Sell
1,762,090
-1,524,471
-46% -$19M 2.88% 15
2026
Q1
$43.1M Buy
3,286,561
+1,205,233
+58% +$21.2M 6.19% 6
2025
Q4
$55.3M Sell
2,081,328
-23,754
-1% -$644K 6.98% 4
2025
Q3
$63.2M Buy
2,105,082
+592,751
+39% +$20.4M 7.47% 2
2025
Q2
$63.5M Sell
1,512,331
-619,407
-29% -$22.4M 7.41% 1
2025
Q1
$66.9M Buy
2,131,738
+8,017
+0.4% +$300K 8.04% 2
2024
Q4
$73.5M Sell
2,123,721
-26,893
-1% -$783K 8.36% 1
2024
Q3
$49.4M Buy
2,150,614
+565,263
+36% +$13.8M 6% 7
2024
Q2
$41.7M Buy
1,585,351
+319,071
+25% +$7.65M 5.28% 9
2024
Q1
$27.6M Buy
+1,266,280
New +$26.9M 3.57% 13

Other funds holding KD

Cortland Associates's KD Position: Q2 2026 in Review

Cortland Associates reduced its Kyndryl (KD) stake by 46% in Q2 2026, selling an estimated $19M and leaving 1,762,090 shares worth $19.9M. The position accounts for 2.88% of the portfolio, ranked #15.

Cortland Associates first reported a position in KD in Q1 2024 and has held it in 10 quarters since. The position peaked at $73.5M in Q4 2024. 671 funds tracked by Wall St. Rank hold KD as of Q2 2026.

  • Cortland Associates held 1,762,090 shares of Kyndryl worth $19.9M as of Q2 2026.
  • Cortland Associates sold 1,524,471 Kyndryl shares in Q2 2026, an estimated $19M.
  • Kyndryl made up 2.88% of Cortland Associates's portfolio in Q2 2026, its #15 holding.
  • Cortland Associates first reported a position in Kyndryl in Q1 2024 and has held it in 10 quarters since.
  • Cortland Associates's Kyndryl position peaked at $73.5M in Q4 2024.
  • 671 funds tracked by Wall St. Rank held Kyndryl as of Q2 2026.

Based on Cortland Associates's 13F filing for Q2 2026, filed 28 Jul 2026.